The Effect of Rivastigmine Transdermal Patch on Sleep Apnea in Patients with Probable Alzheimer’s Disease
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background and Purpose This study was designed to evaluate the effect on sleep of rivastigmine transdermal patch in patients with probable Alzheimer’s disease (AD). Methods Patients with probable AD underwent a sleep questionnaire, overnight polysomnography and neuropsychological tests before and after rivastigmine transdermal patch treatment. We analyzed the data from enrolled patients with AD. Results Fourteen patients with probable AD were finally enrolled in this study. The respiratory disturbance index after the rivastigmine patch treatment was improved in patients with probable AD and sleep breathing disorder, compared with that of before treatment (p<0.05). Conclusions Rivastigmine transdermal patch application are expected to improve the symptoms of sleep disordered breathing in patients with probable AD. Further placebo controlled studies are needed to confirm these results.
Abstract
Background and Purpose This study was designed to evaluate the effect on sleep of rivastigmine transdermal patch in patients with probable Alzheimer’s disease (AD). Methods Patients with probable AD underwent a sleep questionnaire, overnight polysomnography and neuropsychological tests before and after rivastigmine transdermal patch treatment. We analyzed the data from enrolled patients with AD. Results Fourteen patients with probable AD were finally enrolled in this study. The respiratory disturbance index after the rivastigmine patch treatment was improved in patients with probable AD and sleep breathing disorder, compared with that of before treatment (p<0.05). Conclusions Rivastigmine transdermal patch application are expected to improve the symptoms of sleep disordered breathing in patients with probable AD. Further placebo controlled studies are needed to confirm these results.
참고문헌 (28)
- Moran M, "Sleep disturbance in mild to moderate Alzheimer’s disease", Sleep Med, 6, pp.347~352 (2005)
- Bliwise DL., "Sleep disorders in Alzheimer’s disease and other dementias", Clin Cornerstone, 6(Suppl 1A), pp.S16~S28 (2004)
- Bellingham MC, "Contribution of cholinergic systems to state-dependent modulation of respiratory control", Respir Physiol Neurobiol, 131, pp.135~144 (2002)
- Gilman S, "Cerebral cortical and subcortical cholinergic deficits in parkinsonian syndromes", Neurology, 74, pp.1416~1423 (2010)
- McKhann G, "Clinical diagnosis of Alzheimer’s disease : report of the NINCDSADRDA Work Group under the auspices of department of health and human services task force on Alzheimer’s disease", Neurology, 34, pp.939~944 (1984)
- Kang Y, "A validity study on the Korean Mini-Mental State Examination(K-MMSE)in dementia patients", J Korean Neurol Assoc, 15, pp.300~308 (1997)
- Johns MW, "A new method for measuring daytime sleepiness : the Epworth Sleepiness Scale", Sleep, 14, pp.540~545 (1991)
- Herscovitch J, "Sensitivity of the stanford sleepiness scale to the effects of cumulative partial sleep deprivation and recovery oversleeping", Sleep, 4, pp.83~91 (1981)
- Beck AT, "An inventory for measuring depression", Arch Gen Psychiatry, 4, pp.561~571 (1961)
- Iber C, "The AASM manual for the scoring of sleep and associated events: rules, terminology, and technical specification", American Academy of Sleep Medicine, ~ (2007)
- Choi SH, "Estimating the validity of the Korean version of expanded clinical dementia rating(CDR)scale", J Korean Neurol Assoc, 19, pp.585~591 (2001)
- Rosen WG, "A new rating scale for Alzheimer’s disease", Am J Psychiatry, 141, pp.1356~1364 (1984)
- Gehrman PR, "Sleep-disordered breathing and agitation in institutionalized adults with Alzheimer disease", Am J Geriatr Psychiatry, 11, pp.426~433 (2003)
- Peppard PE, "Prospective study of the association between sleep-disordered breathing and hypertension", N Engl J Med, 342, pp.1378~1384 (2000)
- Ancoli-Israel S, "Cognitive effects of treating obstructive sleep apnea in Alzheimer’s disease : a randomized controlled study", J Am Geriatr Soc, 56, pp.2076~2081 (2008)
- Cooke JR, "Sustained use of CPAP slows deterioration of cognition, sleep, and mood in patients with Alzheimer’s disease and obstructive sleep apnea : a preliminary study", J Clin Sleep Med, 5, pp.305~309 (2009)
- White DP, "Pharmacologic approaches to the treatment of obstructive sleep apnea", Sleep Med Clin, 11, pp.203~212 (2016)
- Riemann D, "Effect of tetrahydroaminoacridine on sleep in healthy subjects", Biol Psychiatry, 39, pp.796~802 (1996)
- Moraes W, "Donepezil improves obstructive sleep apnea in Alzheimer disease : a double-blind, placebo-controlled study", Chest, 133, pp.677~683 (2008)
- Sukys-Claudino L, "Beneficial effect of donepezil on obstructive sleep apnea : a doubleblind, placebo-controlled clinical trial", Sleep Med, 13, pp.290~296 (2012)
- Winblad B, "Use of rivastigmine transdermal patch in the treatment of Alzheimer’s disease", Expert Opin Drug Deliv, 5, pp.1377~1386 (2008)
- Kurz A, "Pharmacokinetics of a novel transdermal rivastigmine patch for the treatment of Alzheimer’s disease : a review", Int J Clin Pract, 63, pp.799~805 (2009)
- 한현정, "Efficacy and Safety of Switching from Oral Cholinesterase Inhibitors to the Rivastigmine Transdermal Patch in Patients with Probable Alzheimer’s Disease", Journal of Clinical Neurology, 7(3), pp.137~142 (2011), 대한신경과학회
- Schredl M, "The effect of rivastigmine on sleep in elderly healthy subjects", Exp Gerontol, 35, pp.243~249 (2000)
- Kanbayashi T, "Effects of donepezil(Aricept)on the rapid eye movement sleep of normal subjects", Psychiatry Clin Neurosci, 56, pp.307~308 (2002)
- Schredl M, "Donepezil-induced REM sleep augmentation enhances memory performance in elderly, healthy persons", Exp Gerontol, 36, pp.353~361 (2001)
- Grossberg GT, "Reviews : effects of transdermal rivastigmine on ADAS-cog items in mild-to-moderate Alzheimer’s disease", Am J Alzheimers Dis Other Demen, 25, pp.627~633 (2010)
- Lim AS, "Sleep is related to neuron numbers in the ventrolateral preoptic", intermediate nucleus in older adults with and without Alzheimer’s disease, 2014, pp.137(Pt 10), 2847~2861
